Home/Supira Medical/Nitin Salunke

NS

Nitin Salunke

President & CEO

Therapeutic Areas

Supira Medical Pipeline

Drug	Indication	Phase
Next Generation pVAD	Temporary mechanical circulatory support for High-Risk Percutaneous Coronary Intervention (PCI) and Cardiogenic Shock (CS)	Pivotal

Leadership Team at Supira Medical

Chief Financial Officer

Janine Robinson

Sr. Vice President, R&D

Sr. Vice President, Systems Engineering

View full Supira Medical profile